Concepedia

Yi Wang

YW

8

Publications

201

Citations

8

H-Index

2009

Active since

Affiliations

Huaian First People’s Hospital(Current)

Mitsubishi Corporation (United States)

Peking University People's Hospital

Peking University

Yi Wang is an author at Huaian First People’s Hospital specializing in cellular biochemistry, drug discovery, and molecular pharmacology.

ORCID

Top concepts

Publications per year

2009–2021

8

Publications

8

Effects of the dual sodium–glucose linked transporter inhibitor, licogliflozin <i>vs</i> placebo or empagliflozin in patients with type 2 diabetes and heart failure

Rudolf A. de Boer, Julio Núñez, Plamen Kozlovski et al. · British Journal of Clinical Pharmacology · 2020 · 63 citations · Full text

Genetic variants of OCT1 influence glycemic response to metformin in Han Chinese patients with type-2 diabetes mellitus in Shanghai.

Yong Zhou, Weiwei Ye, Yi Wang et al. · PubMed · 2015 · 49 citations

Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis

Yi Wang, Yan‐Hui Liu, Shi‐Juan Mai et al. · Journal of Gastroenterology and Hepatology · 2009 · 28 citations

<scp> Na <sup>+</sup> /H <sup>+</sup> </scp> exchanger 3 blockade ameliorates type 2 diabetes mellitus via inhibition of sodium‐glucose co‐transporter 1‐mediated glucose absorption in the small intestine

Leo Chan, Yi Wang, Enders K. Ng et al. · Diabetes Obesity and Metabolism · 2017 · 14 citations

The potential DPP-4 inhibitors from Xiao-Ke-An improve the glucolipid metabolism via the activation of AKT/GSK-3β pathway

Shumin Jiang, Xueli Wu, Yi Wang et al. · European Journal of Pharmacology · 2020 · 13 citations

, , +14

Rows per page

1–5 of 8